Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor

MLA

Kimme L. Hyrich, et al. “Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.” Arthritis Care & Research, vol. 69, May 2017, pp. 783–93. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........bde0cdb9abc38a7a4c0393c20a9a11a3&authtype=sso&custid=ns315887.

APA

Kimme L. Hyrich, Philip D H Hamann, Gavin Shaddick, Richard Holland, Neil McHugh, Alison Nightingale, & John D Pauling. (2017). Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor. Arthritis Care & Research, 69, 783–793.

Chicago

Kimme L. Hyrich, Philip D H Hamann, Gavin Shaddick, Richard Holland, Neil McHugh, Alison Nightingale, and John D Pauling. 2017. “Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.” Arthritis Care & Research 69 (May): 783–93. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........bde0cdb9abc38a7a4c0393c20a9a11a3&authtype=sso&custid=ns315887.